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Access to liver transplantation is reportedly inequitable for racial/ethnic minorities, but inadequate adjustments for geogra-
phy and disease progression preclude any meaningful conclusions. We aimed to evaluate the association between candi-
date race/ethnicity and liver transplant rates after thorough adjustments for these factors and to determine how uniform
racial/ethnic disparities were across Model for End-Stage Liver Disease (MELD) scores. Chronic end-stage liver disease
candidates initially wait-listed between February 28, 2002 and February 27, 2007 were identified from Scientific Registry for
Transplant Recipients data. The primary outcome was deceased donor liver transplantation (DDLT); the primary exposure
covariate was race/ethnicity (white, African American, Hispanic, Asian, and other). Cox regression was used to estimate the
covariate-adjusted DDLT rates by race/ethnicity, which were stratified by the donation service area and MELD score. With
averaging across all MELD scores, African Americans, Asians, and others had similar adjusted DDLT rates in comparison
with whites. However, Hispanics had an 8% lower DDLT rate versus whites [hazard ratio (HR) ¼ 0.92, P ¼ 0.011]. The dis-
parity among Hispanics was concentrated among patients with MELD scores < 20, with HR ¼ 0.84 (P ¼ 0.021) for MELD
scores of 6 to 14 and HR ¼ 0.85 (P ¼ 0.009) for MELD scores of 15 to 19. Asians with MELD scores < 15 had a 24%
higher DDLT rate with respect to whites (HR ¼ 1.24, P ¼ 0.024). However, Asians with MELD scores of 30 to 40 had a
46% lower DDLT rate (HR ¼ 0.54, P ¼ 0.004). In conclusion, although African Americans did not have significantly different
DDLT rates in comparison with similar white candidates, race/ethnicity-based disparities were prominent among subgroups
of Hispanic and Asian candidates. By precluding the survival benefit of liver transplantation, this inequity may lead to excess
mortality for minority candidates. Liver Transpl 16:1033-1040, 2010. VC 2010 AASLD.
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The US Census Bureau projects that the US popula-
tion will undergo rapid racial and ethnic diversifica-
tion over the next 50 years. Minority populations
are expected to grow by 2% per year over the next 3
decades in the United States. The African American
population is expected to grow to encompass 15% of
the US population, whereas Asian and Pacific
Islanders will make up approximately 9%. Although
Hispanics, making up 15% of the US population,
are currently the single largest ethnic minority
group, they are projected to account for nearly a
quarter of the population by 2050 (130 million in
all).1 Recent data also suggest that the incidence of
chronic liver disease and hepatocellular carcinoma
(HCC) is growing fastest in minority populations,
particularly among Hispanics.2-8 The rapid diversifi-
cation of the US population, coupled with the grow-
ing burden of liver disease in minority communities,
suggests that the liver transplant waiting list of the
future will have greater racial, ethnic, and cultural
pluralism than it does currently.
Abbreviations: DDLT, deceased donor liver transplantation; DSA, donation service area; HCC, hepatocellular carcinoma; HR,
hazard ratio; HRSA, Health Resources and Services Administration; MELD, Model for End-Stage Liver Disease; OPTN, Organ
Procurement and Transplant Network; SD, standard deviation; SRTR, Scientific Registry of Transplant Recipients.
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The need for racial/ethnic equity in liver transplanta-
tion among patients with the same medical urgency is
necessary, but previous studies in this area have been
narrow in their conception of race, have been poten-
tially biased, or have been derived from cohorts of can-
didates who were wait-listed under obsolete allocation
rules. African Americans reportedly had significantly
lower transplant rates in the era prior to the adoption
of the Model for End-Stage Liver Disease (MELD)–based
liver allocation system,9,10 with improvement in the
disparity supposedly occurring in the MELD era.3,10
These studies have failed to provide a complete evalua-
tion of other minority groups, such as Hispanics and
Asians, who account for a growing proportion of the
waiting list.11 Furthermore, previous disparity-related
studies have not correctly adjusted for geographic fac-
tors that may affect the receipt of a liver transplant.
The variation in the likelihood of receiving a liver trans-
plant in different parts of the country has been well
documented12-14 and is tied to the local availability of
organs from deceased donors, the performance of
organ procurement organizations, and transplant pro-
gram practices.15,16 In order to better understand and
address racial/ethnic disparities in liver transplanta-
tion in a policy framework, studies on racial/ethnic eq-
uity in liver transplantation must provide a more pre-
cise estimate of the scope of the problem by accounting
for potential confounding factors.
Because of the growing racial/ethnic diversity of the
liver waiting list, the intent of our study was to compre-
hensively characterize racial/ethnic disparities in
access to liver transplantation in the context of the liver
allocation system. Using data from the Scientific Regis-
try of Transplant Recipients (SRTR), we aimed to evalu-
ate any potential racial/ethnic inequity in wait-list event
rates by accounting for patient differences, changes in
disease over time, and geographic factors, all of which
affect transplant rates.17 We also aimed to determine to
what extent different levels of geographic adjustment
[the local donation service area (DSA) level, the Organ
Procurement and Transplant Network (OPTN) regional
level, and groups of OPTN regions] affect measured dif-
ferences in adjusted liver transplant rates between
racial/ethnic groups. The liver allocation system is
driven by the principle of medical urgency and theoreti-
cally is able to achieve equity in access to transplanta-
tion by remaining true to objective characterizations of
liver disease severity.18 Using a carefully designed sta-
tistical approach that modeled access to liver transplan-
tation based on the rules of liver allocation, we intended
to identify any racial/ethnic disparities that were
byproducts of the design of the allocation system.
PATIENTS AND METHODS
Data were obtained from the SRTR and were based on
patient-level data submitted by transplant centers to
the OPTN. After the exclusion of patients with acute
liver failure (status 1), those under the age of 18
years, and those with previous liver transplants, the
study population (n ¼ 39,114) consisted of adult
chronic end-stage liver disease candidates initially
added to the waiting list between February 28, 2002
and February 27, 2007. The start date corresponded
to the initiation date of MELD-based liver allocation
by the OPTN, whereas the end date was chosen so
that up to 5 years of follow-up data were available.
In our analysis, race and ethnicity were considered
jointly. Both race and ethnicity represent a social con-
text that frames personal and cultural identity, atti-
tudes toward health, health practices, and behavioral
risks that may precipitate disease. These construc-
tions may also shape patient interactions with the
health care system by affecting the expectations and
perceptions of both the patients and the providers in
health care encounters.19 We used race and ethnicity
definitions provided by transplant centers with the
OPTN data collection infrastructure. Race and ethnic-
ity were defined as non-Hispanic white (white), African
American, Hispanic, Asian, or other, with the last
including Native Americans, Native Alaskans, Native
Hawaiians, and those of undefined or mixed race/eth-
nicity (eg, black Hispanics). Our principal aim was to
determine whether deceased donor liver transplanta-
tion (DDLT) rates differed by candidate race/ethnicity.
Cox regression was used to compare race/ethnicity-
specific rates of DDLT among active patients.20 Follow-
up began for patients when they were initially added to
the waiting list. They were followed until the earliest of
liver transplantation, death, the granting of a MELD
exception score, or the end of the observation period
(February 27, 2007). In order to assess the workings of
the allocation system, we modeled the rate of DDLT
among active patients because donor livers cannot be
allocated to those who are inactivated, are removed
from the waiting list, or die on the waiting list.21 Corre-
spondingly, follow-up data for patients who were
removed from the waiting list or were inactive for any
period of time (eg, for temporary illnesses or other
issues that precluded liver transplantation) were
excluded. Observation of a patient was subsequently
reinitiated if and when the patient was reactivated.
Patients were censored from the analysis at the time at
which they received a living donor liver transplant or a
MELD exception score (eg, for HCC), if this was applica-
ble. Differences in access to liver transplantation were
represented by hazard ratios (HRs) and were expressed
as percentage changes in relative rates.
The Cox models were stratified by the integer MELD
score and included several covariates from the SRTR
candidate file; this included age, gender, diagnosis, di-
abetes, body mass index, hospitalization status at
listing, receipt of dialysis, albumin, and prior malig-
nancy. The MELD score, albumin level, and use of di-
alysis were time-dependent covariates, and this meant
that all of a candidate’s changes with respect to such
factors recorded in data submitted to the OPTN were
incorporated into the analysis. In all, 98 patients had
at least 1 missing data element in the baseline adjust-
ment covariates, and these patients were excluded.
In order to study the effect of geography on meas-
ured differences in transplant rates between minority
1034 MATHUR ET AL. LIVER TRANSPLANTATION, September 2010
groups and whites, we created 3 separate geographic
adjustment models. A previous study, using a model
adjusted for geography with consolidated OPTN
regions, identified African Americans as having signifi-
cantly decreased transplant rates with respect to
whites.10 We created 2 additional models, one adjusted
for each individual OPTN region and another adjusted
for the DSA, the primary level of organ distribution. By
comparing these 3 models, we could identify how trans-
plant rates differed between minority groups and
whites registered in the same geographic unit. Subse-
quent comparisons of racial/ethnic differences in
adjusted DDLT rates were obtained with models strati-
fied by the DSA in addition to the MELD score.
Further analysis was directed toward evaluating
whether the association between race/ethnicity and
liver transplant rates was modified by medical ur-
gency or geography (ie, interactions). First, to deter-
mine if the impact of race/ethnicity differed by medi-
cal urgency, we fitted models that estimated separate
MELD category–specific race/ethnicity effects. This
involved fitting models with product terms defined by
indicators for the race/ethnicity group and MELD cat-
egory. MELD categories were based on a modification
of the ranges based on liver transplant survival bene-
fit.22 These categories were MELD ranges of 6 to 14,
15 to 19, 20 to 29, and 30 to 40, and they were
derived by the grouping of candidates with adjacent
MELD scores to ensure an adequate number of trans-
plant events in each group. Second, we fitted models
that enabled direct comparisons of relative transplant
rates between racial/ethnic minorities and whites reg-
istered in the same DSAs within each OPTN region.
We also fitted additional models to determine whether
race/ethnicity affected the transitions from active
wait-list status to inactivation, removal, and death,
which were stratified by the integer MELD score and
DSA. These models were censored at transplantation
and the granting of a MELD exception. Models to
determine the effect of race/ethnicity and MELD
interactions on these other outcomes were also fitted.
This study was approved by the US Health Resour-
ces and Services Administration (HRSA) SRTR project
officer. HRSA determined that this study satisfied the
criteria for the institutional review board exemption
described in the Public Benefit and Service Program
provisions of 45 CFR 46.101(b)(5) and HRSA Circular
03. All statistical analysis was performed with SAS
version 9.2 (SAS Institute, Cary, NC). Statistical sig-
nificance was defined as P < 0.05.
RESULTS
Clinical characteristics of the 39,114 patients in the
study population are displayed in Table 1. Whites
made up 74.1% of wait-listed patients, Hispanics
made up 13.9%, African Americans made up 7.3%,
Asians made up 3.7%, and others made up less than
1%. Racial/ethnic subgroups were significantly differ-
ent with respect to the following factors: age at wait-
listing, sex, diagnosis, MELD score at listing, body
mass index, and percentage of patients on dialysis,
with P < 0.0001 in each case. The mean age at wait-
list registration ranged from 49.5 (African Americans)
to 53.6 years (Asians). The proportion of male candi-
dates was lowest in the Other group (57.8% male) and
highest in the Asian population (68.2% male). With
respect to diagnosis, African Americans also had the
highest proportion of hepatitis C candidates. African
Americans had the highest proportion of patients with
cholestatic liver disease, and Asian and other candi-
dates had the highest proportions of patients with
noncholestatic liver disease. Hepatitis B was not the
sole cause of liver failure for any individual racial/
ethnic group, and this was congruent with previously
reported national data.23 The median MELD score at
listing was at least 2 points higher for African Ameri-
cans versus whites, Hispanics, or Asians. At trans-
plant, African Americans and Hispanics had the high-
est median MELD scores. Hispanics had a
significantly higher proportion of blood type O candi-
dates. Whites had the highest proportion of blood type
A candidates. Asians had the highest proportions of
blood type B and AB candidates. With respect to
comorbidities, African Americans had the highest pro-
portion of dialysis-dependent candidates; 8.1% to
10.3% of the candidates had diabetes, and there were
significantly more diabetics among Hispanics versus
the other groups. The mean body mass index was low-
est among Asian candidates and highest among His-
panic candidates. Of all groups, African Americans
had the highest proportion of candidates on dialysis
at registration.
The geographic variation in measured disparities in
liver transplant rates between minorities and whites
is represented in Fig. 1. Each bar represents the dif-
ference in adjusted liver transplant rates between
African Americans and whites for a defined unit of ge-
ographic comparison. When relative transplant rates
were compared between African Americans and whites
registered in the same quadrant of the country
(grouped contiguous OPTN regions: northeast, south-
east, northwest, and southwest), in agreement with
the geography adjustment by Moylan et al.,10 African
Americans had a significantly lower adjusted trans-
plant rate (by 10%) versus whites, with a covariate-
adjusted HR of 0.90 (P ¼ 0.0001). Similarly, when
African Americans and whites registered in the same
OPTN region were compared, the relative transplant
rate was also significantly lower for African Americans
(HR ¼ 0.87, P ¼ 0.0001). However, when African
Americans and whites registered in the same DSA
were compared, the disparity between African Ameri-
cans and whites was minimal and not statistically sig-
nificant (HR ¼ 0.98, P ¼ 0.50).
Figure 2 displays the risk-adjusted differences in
relative liver transplant rates for African Americans,
Hispanics, Asians, and those of other race/ethnicity
versus whites. The nonsignificant 2% lower rate for
African Americans (adjusted for the DSA) is as
described in Fig. 1. In contrast to African Americans,
Hispanics had a significantly lower liver transplant
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rate (by 8%) versus whites (HR ¼ 0.92, P ¼ 0.011).
Candidates who were Asian or of other race/ethnicity
had no significant differences in liver transplant rates
versus whites. Interaction tests between race/ethnic-
ity, sex, and diagnosis were not significant.
In order to sharpen our understanding of which
subsets of minority candidates were affected by the
disparity, we determined differences in transplant
rates within each MELD stratum (Fig. 3). There were
no significant differences in liver transplant rates
between African Americans and whites at any MELD
scores. Asian candidates with lower MELD scores had
a 24% higher transplant rate with respect to whites
with the same scores (HR ¼ 1.24, P ¼ 0.024), but the
sickest Asian patients had nearly half the transplant
rate of their white counterparts (HR ¼ 0.54, P ¼
0.004). Hispanic candidates who were registered in
the same DSA displayed 15% to 16% lower transplant
rates in comparison with whites when they had MELD
scores less than 20, with HR ¼ 0.84 (P ¼ 0.021) for
MELD scores of 6 to 14 and HR ¼ 0.85 (P ¼ 0.009) for
MELD scores of 15 to 19. With MELD scores above
20, Hispanics and whites did not have significantly
different transplant rates within the same DSA.
Racial/ethnic differences were noted in other wait-
list events as well. Compared with whites, African
Americans had significantly lower wait-list removal
rates for reasons other than transplantation (HR ¼
0.93, P ¼ 0.004). Similarly, Asians also had signifi-
cantly lower nontransplant removal rates (HR ¼ 0.89,
P ¼ 0.009). Hispanics trended toward a lower removal
rate in comparison with whites, but this was not stat-
istically significant (HR ¼ 0.96, P ¼ 0.073). With
respect to racial/ethnic differences in wait-list mortal-
ity, African Americans, while active on the wait list,
had a 37% lower mortality rate than whites (HR ¼
0.63, P < 0.0001). Asians maintained a 27% lower
mortality rate versus whites (HR ¼ 0.73, P ¼ 0.007).
Hispanics did not have a significantly different death
rate in comparison with whites. There were no signifi-
cant differences in wait-list inactivation rates by race/
ethnicity.
DSA-adjusted transplant rates for African Ameri-
cans, Hispanics, and Asians varied extensively across
OPTN regions (Fig. 4). However, after covariate adjust-
ments, 7 of 11 OPTN regions displayed no significant
differences in transplant rates when the respective
minority groups were compared with whites. No single
TABLE 1. Clinical Characteristics of Wait-Listed Liver Transplant Candidates in the Study Cohort by Race/Ethnicity in











(n ¼ 358) P Value
Age at wait-list registration,
years [mean (SD)]
52.6 (9.3) 49.5 (10.5) 52.0 (9.5) 53.6 (10.5) 50.5 (9.5) <0.0001
Sex [n (%)] <0.0001
Male 19,203 (66.2) 1702 (59.4) 3341 (61.3) 989 (68.2) 207 (57.8)
Female 9786 (33.8) 1163 (40.6) 2111 (38.7) 461 (31.8) 151 (42.2)
Diagnosis [n (%)] <0.0001
Cholestatic 2850 (9.8) 314 (11.0) 299 (5.5) 62 (4.3) 29 (8.1)
Noncholestatic 10,311 (35.6) 674 (23.5) 1944 (35.7) 638 (44.0) 145 (45.5)
Hepatitis C 11,511 (39.7) 1405 (49.0) 2566 (47.1) 378 (26.1) 122 (34.1)
Acute hepatic necrosis 429 (1.5) 74 (2.6) 98 (1.8) 83 (5.7) 13 (3.6)
Malignant neoplasm (non-HCC) 650 (2.2) 65 (2.3) 141 (2.6) 99 (6.8) 18 (5.0)
Metabolic disease 630 (2.2) 18 (0.6) 41 (0.8) 13 (0.9) 5 (1.4)
Other 2608 (9.0) 315 (11.0) 363 (6.7) 177 (12.2) 26 (7.3)
Blood type [n (%)] <0.0001
A 11,857 (40.9) 786 (27.4) 1673 (30.7) 362 (25.0) 122 (34.0)
B 3130 (10.8) 589 (20.6) 551 (10.1) 383 (26.4) 37 (10.3)
O 12,901 (44.5) 1371 (47.9) 3102 (56.9) 582 (40.1) 189 (52.7)
AB 1098 (3.8) 119 (4.2) 126 (2.3) 123 (8.5) 11 (3.1)
Body mass index, kg/m2
[mean (SD)]
28.6 (5.8) 28.2 (6.0) 28.9 (5.7) 24.6 (4.3) 29.4 (6.1) <0.0001
Renal failure, dialysis [n (%)] 817 (2.8) 173 (6.0) 225 (4.1) 56 (3.9) 16 (4.5) <0.0001
Diabetes [n (%)] 2551 (8.8) 264 (9.2) 561 (10.3) 117 (8.1) 37 (10.3) 0.0050
Coronary artery disease [n (%)] 460 (1.6) 36 (1.3) 60 (1.1) 10 (0.7) 5 (1.4) 0.0007
Chronic obstructive
pulmonary disease [n (%)]
492 (1.7) 30 (1.1) 47 (0.9) 8 (0.6) 6 (1.7) <0.0001
MELD score at listing
[median (25th, 75th percentiles)]
14 (11, 19) 17 (12, 23) 15 (11, 20) 13 (9, 19) 16 (12, 22)
MELD score at transplant
[median (25th, 75th percentiles)]
18 (13, 24) 20 (13, 26) 20 (12, 27) 14 (7, 21) 19 (14, 24)
NOTE: Percentages are column percentages.
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region demonstrated significant disparities for all mi-
nority groups. African Americans did not have any
statistically significant differences in transplant rates
versus whites in any OPTN region. Region 2, which
includes Pennsylvania, Maryland, New Jersey, Dela-
ware, West Virginia, Washington, DC, and northern
Virginia, demonstrated significantly lower transplant
rates for Hispanics versus whites (HR ¼ 0.77, P ¼
0.021). The access of Asian candidates to liver trans-
plantation varied widely. In region 3, which includes
most of the southeastern United States, Asians dem-
onstrated a 41% higher transplant rate versus whites
(HR ¼ 1.41, P ¼ 0.051). Regions 9 and 10, which con-
tain the DSAs that serve New York, western Vermont,
Ohio, Indiana, and Michigan, demonstrated 36% to
60% lower transplant rates for Asian candidates, with
HR ¼ 0.63 (P ¼ 0.009) for region 9 and HR ¼ 0.40 (P
¼ 0.037) for region 10.
DISCUSSION
Racial/ethnic disparities in transplantation have been
framed as the culmination of a series of successive
barriers in access to care that marginalize minorities
with organ failure.2,17,24-26 Our findings demonstrate
racial/ethnic variation in access to liver transplanta-
tion at a critical step: the transition from transplant
candidate to transplant recipient. Racial/ethnic dis-
parities at this step in the transplant process are im-
portant because liver transplant candidates are a
highly selected population overcoming clinical and
nonclinical barriers to get onto the waiting list.17 The
clinical outcome of these candidates is based on indi-
vidual disease progression, the continued ability to
access specialized hepatological care, and the efficacy
of the liver allocation system. We observed signifi-
cantly lower liver transplant rates for subgroups of
minority candidates versus their white counterparts,
particularly among Hispanic candidates and Asians
with high MELD scores. Importantly, these lower
Figure 1. The apparent deficit in liver transplant access for
African Americans is confounded by geography in the MELD era.
This figure demonstrates the differences in relative transplant
rates between African Americans and whites when they were
compared with 3 different methods of geographic adjustment.
When adjustments were made for geography by grouped
adjacent OPTN regions (as described by Moylan et al.10) and
even by individual OPTN regions, African Americans appeared to
have a significantly lower liver transplant rate than whites in the
same geographic areas. The DSA is the primary geographic unit
of liver allocation in the United States. When African Americans
and whites registered in the same DSA were compared, no
significant difference in access to liver transplantation from the
waiting list was noted.
Figure 2. Racial/ethnic variation in relative liver transplant
rates in the MELD era. According to the DSA level and other risk
adjustments, the relative transplant rates for Hispanics were
significantly lower than those for whites. African Americans had
transplant rates similar to those of whites (see Fig. 1). There was
a small trend toward a 3% higher transplant rate for Asians
versus whites, but it was not significant. For other or mixed race
candidates, there was a nonsignificant trend toward a 3% lower
liver transplant rate versus whites. The models incorporated all
changes in the MELD score reported to the SRTR.
Figure 3. Relative liver transplant rates by race/ethnicity and
MELD score. After further stratification of each racial group by
the MELD score, several findings were prominent. African
Americans did not have significantly different transplant rates
versus whites at any MELD score. Hispanic candidates had
significantly lower transplant rates (by 15%-16%) versus whites
with similar disease severity with MELD scores less than 20.
Asian candidates demonstrated 24% higher liver transplant
rates with the lowest MELD scores but 46% lower transplant
rates with the highest MELD scores. The analysis incorporated
all changes in the MELD scores reported to the SRTR, and these
transplant rate differences reflect the outcomes while candidates
maintained a MELD score within a particular range.
LIVER TRANSPLANTATION, Vol. 16, No. 9, 2010 MATHUR ET AL. 1037
transplant rates were not accompanied by higher
rates of alternate wait-list outcomes, including death,
removal for nontransplant reasons, and inactivation.
By showing geographic heterogeneity in racial/ethnic
differences in access to transplant, we also demon-
strated ‘‘a difference in differences’’ in liver transplant
rates. To the best of our knowledge, our study is the
first to broadly address disparities in access to liver
transplantation across all racial/ethnic groups and to
identify the importance of properly accounting for geo-
graphic variation.
Geographic variation is being increasingly recognized
as a threat to optimizing the use of donated organs12,27
and in our study had a clear effect on the measured dif-
ferences in transplant rates between minorities and
whites. African Americans did not have different
adjusted transplant rates versus whites when they were
compared at the DSA level. Moylan and colleagues10
previously studied access to liver transplantation for
African American and white candidates and also found
no differences in transplant rates. By grouping OPTN
regions together, they imprecisely adjusted for geogra-
phy and suggested, for example, that candidates in
Florida have access to transplantation similar to the
access of candidates in Texas, even though organ avail-
ability is highly variable across DSAs. Furthermore,
they did not evaluate ethnic minorities other than Afri-
can Americans and did not account for changes in the
severity of liver disease over time while candidates were
wait-listed. It was therefore appropriate to evaluate
racial/ethnic disparity in access to transplantation at
the DSA level to improve precision in our estimates.
Our findings suggest that the locale in which candi-
dates seek care for their liver disease modifies the effect
of race/ethnicity on access to liver transplantation.
Volk and colleagues16 assessed disparities in access
to liver transplantation and suggested that differences
in the median waiting time between DSAs, a proxy for
organ availability, mediated racial/ethnic inequity.
Our analyses differ from their work in several impor-
tant ways. In contrast to Volk et al., who focused on
African Americans and Hispanics, we evaluated dis-
parities across all racial/ethnic groups, including
whites, African Americans, Hispanics, Asians, and
those of mixed or other ethnic heritage. We specifically
focused on the identification of residual disparities
within MELD subgroups and geographic areas. Meth-
odologically, this focus was manifested in our mea-
surement of racial/ethnic differences in transplant
rates during active wait-list time and in our exhaus-
tive treatment of the intersection of race/ethnicity,
MELD score, and geography. In addition, we gave due
consideration to competing risks, including inactiva-
tion, removal for reasons other than transplant, and
death. Volk et al. considered any difference in trans-
plant rates after registration to be a disparity.
Figure 4. Regional variation in access to liver transplantation for minority candidates. Across all minority groups, the 11 OPTN
regions covering the United States demonstrated an impressive degree of variation in relative transplant rates in comparison with
white candidates. Four regions demonstrated significantly different transplant rates for a minority group versus whites. Five regions
trended toward lower transplant rates for African Americans versus whites. Six regions demonstrated trends toward lower liver
transplant rates for Hispanics, and the rates in region 2 reached statistical significance in this respect. For Asian candidates, 7
regions trended toward lower access to liver transplantation in comparison with whites. Regions 9 and 10 had much lower transplant
rates for these candidates versus their respective white counterparts, but region 3 had significantly higher transplant rates for Asians.
The analysis incorporated all changes in the MELD scores reported to the SRTR. An asterisk indicates significance.
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However, because of the dynamic nature of the liver
transplant wait list, their failure to identify a disparity
in access among Hispanics was predicated, in the ab-
sence of analysis, on there being no racial/ethnic dif-
ferences in rates of inactivation, reactivation, removal
for reasons other than transplant, and granting of
MELD exception scores. Our approach addressed
these realities for African American, Hispanic, and
Asian candidates in the context of allocation rules
that are intended to apply to all candidates and also
accounted for the extent to which geography modified
the effect of race and ethnicity.
An important finding in this study was the lack of an
overall disparity in transplant rates between African
Americans and whites. This was also true across MELD
scores and OPTN regions. This contrasts with a pre-
MELD era study by Reid et al.,9 who reported signifi-
cant disparities in access to transplantation for African
Americans. African Americans did present with more
advanced disease at registration in comparison with
whites in our study, but the equitable transplant rate
observed after we accounted for this advanced disease
is the intended result of a medical urgency–based organ
allocation system. However, registration on the wait list
with more advanced disease signifies an important and
persistent issue in the continuum of care of patients
with liver disease, as suggested by Moylan et al.10 The
delay in wait-list registration likely symbolizes impaired
access to quality pretransplant care and may indicate
that African Americans suffer from greater disease-
related morbidity before registration.2,17,28,29 Further
study on the timeliness and appropriateness of physi-
cian referral of African Americans with chronic liver dis-
ease to transplant centers is clearly a necessity.
The disparities noted in this analysis must be consid-
ered in the context of whether patients receive a sur-
vival benefit with a liver transplant. Once a patient
reaches a MELD score of 12 or higher, the survival ben-
efit of receiving a liver transplant is realized.30 His-
panics with MELD scores of 6 to 14 had a 16% lower
transplant rate and those with MELD scores of 15 to 20
had a 15% lower transplant rate versus whites with the
same MELD scores. Asians with MELD scores of 6 to
14 had a 24% higher transplant rate, whereas those
with highest MELD scores had a 46% lower transplant
rate in comparison with whites with the same MELD
scores. Minority candidates who have lower transplant
rates at the lowest MELD scores arguably do not suffer
from a disparity because these patients with well-com-
pensated disease are unintentionally spared the risk of
a liver transplant. Conversely, Asians are potentially
harmed by a higher transplant rate at low MELD
scores.22 The lower transplant rate at high MELD
scores also disadvantages Asians because liver trans-
plantation provides, at this end of the MELD spectrum,
the most survival benefit. In aggregate, our data indi-
cate which subgroups of minority candidates truly have
impaired access to liver transplantation.
Another contribution of this analysis is the demonstra-
tion of variation in relative transplant rates for members
of individual racial/ethnic groups by geography. Region 2
had a significantly lower transplant rate for Hispanic can-
didates compared with whites, with notable trends to-
ward lower access in five other OPTN regions. Transplant
rates for Asian candidates varied tremendously across
the country, with 3 regions showing significantly different
access for those candidates in comparison with whites.
Region 3 demonstrated a more than 40% higher rate of
transplantation for Asians, and regions 9 and 10 had sig-
nificantly lower transplant rates for Asians versus whites.
Additionally, 5 other regions trended toward lower trans-
plant rates for Asians. Although African Americans
trended toward lower transplant rates in 5 regions, there
was no statistically significant difference in adjusted
transplant rates between African Americans and whites
in any region. The geographic analysis has some limita-
tions with respect to statistical power, but identification
of the geographic areas that have marginal access for a
particular racial/ethnic group may help providers gain
insight into practice patterns that may be responsible for
these observations. This variation may be tied to differen-
ces in clinical decision making by transplant surgeons
that may be driven by the candidate’s clinical condition
as well as the local and regional realities of organ avail-
ability. Furthermore, providers may manage their waiting
lists differently according to their specific candidates, the
proximity of other liver transplant programs, organ ac-
ceptance patterns, and many other factors. Geographic
variation may modify racial/ethnic effects via the pro-
viders themselves. Some areas may have more diversity
among transplant providers and may provide patients
the opportunity for more racially/ethnically concordant
patient-physician interactions, which may ultimately
decrease undesirable wait-list outcomes for minority
candidates.
Our study has some limitations. Although our study
cohort is the largest to date concerning racial/ethnic
disparities in liver transplant rates, our statistical mod-
els are limited by the covariates in the SRTR data. We
have previously recommended the collection of more
granular data, specifically with respect to measuring
disparities in transplantation.17 Patients were also cen-
sored when they received a MELD exception for HCC;
this is growing in incidence among minorities and
accounts for 15% to 20% of the US liver transplant vol-
ume.11,31 Our focus was to identify disparities through
the use of a clinically homogeneous population, and
MELD exceptions artificially boost access to liver trans-
plantation. Differential access to these exceptions,
depending on variations in pathophysiology, geographic
differences in the granting of MELD exceptions, and
variations in the use of adjuvant therapies, might have
biased our understanding of disparities if we had con-
tinued our observation of patients beyond the granting
of MELD exceptions. Finally, these data represent sum-
mative population-based estimates and are not immedi-
ately usable by individual patients trying to determine
their chances of receiving a liver transplant versus
others or deciding where they should pursue liver
transplant candidacy. The effect of race or ethnicity on
transplant rates cannot be ascribed to individual
patients in that group.
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Previous authors have noted that, although this is
not specifically prescribed by the Final Rule, alloca-
tion based on medical urgency should have the benef-
icent effect of racial/ethnic equity.32 Most transplant
physicians, surgeons, and policy makers would agree
that the current liver allocation system is fairer than
that of a decade ago, but as we have demonstrated, it
is not yet equitable. Our work demonstrates that
members of rapidly growing segments of the popula-
tion developing liver disease have impaired access to
a lifesaving treatment. Balancing values in the alloca-
tion of scarce medical resources is unique to trans-
plantation and will continue to challenge the trans-
plant community until the organ supply meets the
demand. Although providing members of certain
racial/ethnic groups with an advantage in allocation
in order to improve equity seems unethical, the public
and the transplant community have a responsibility
to thoroughly evaluate allocation policy changes for
the potential to precipitate or exacerbate unintended
disparities. If we remain vigilant and cognizant of
these important issues in the development of trans-
plant policy and in research on disparities, equity and
sensible liver transplant allocation policy do not need
to be mutually exclusive.
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